Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Bcl-2 family of proteins is a group of evolutionarily related regulators that control apoptosis and maintain the balance between cell survival and death. They are divided into anti-apoptotic, pro-apoptotic multidomain, and pro-apoptotic BH3-only subgroups. Their interactions determine cell fate, and dysregulation is implicated in various diseases, including cancer, neurodegenerative, and autoimmune diseases.
Inhibition of anti-apoptotic proteins or activation of pro-apoptotic proteins, leading to mitochondrial outer membrane permeabilization and caspase activation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bcl-2 family protein (Bcl-2).